Cargando…
Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care
BACKGROUND: The Fred Hutchinson Cancer Research Center has engaged an External Stakeholder Advisory Group (ESAG) in the planning and implementation of the TrACER Study (S1415CD), a five-year pragmatic clinical trial assessing the effectiveness of a guideline-based colony stimulating factor standing...
Autores principales: | Barger, Sarah, Sullivan, Sean D., Bell-Brown, Ari, Bott, Brad, Ciccarella, Anne Marie, Golenski, John, Gorman, Mark, Johnson, Judy, Kreizenbeck, Karma, Kurttila, Florence, Mason, Ginny, Myers, Jamie, Seigel, Carole, Wade, James L., Walia, Guneet, Watabayashi, Kate, Lyman, Gary H., Ramsey, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560751/ https://www.ncbi.nlm.nih.gov/pubmed/31185918 http://dx.doi.org/10.1186/s12874-019-0764-2 |
Ejemplares similares
-
An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD
por: Bell-Brown, Ari, et al.
Publicado: (2022) -
Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD
por: Watabayashi, Kate K., et al.
Publicado: (2022) -
14,15-Didehydrohellebrigenin
por: Yu, Tong, et al.
Publicado: (2012) -
Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing: A Cluster Randomized Clinical Trial
por: Ramsey, Scott D., et al.
Publicado: (2022) -
14,15-Epoxyeicosa-5,8,11-trienoic
Acid (14,15-EET)
Surrogates: Carboxylate Modifications
por: Falck, John R., et al.
Publicado: (2014)